MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1258/175404507780456719

Медицинская библиотека · Menopause international · 2007

Management of premature menopause.

Pitkin Joan, Rees Margaret C P, Gray Sarah, Lumsden Mary Ann, Marsden Jo, Stevenson John C, Williamson Jennifer

СтатьяОбзорПеревод в очереди

Аннотация

There has been some confusion among women and health professionals since the publication of the Women's Health Initiative and Million Women studies about the management of premature ovarian failure (POF). Both studies were undertaken in women aged 50 and over, and cannot be extrapolated to their younger counterparts, who would normally be producing their endogenous estrogen, since they have functioning ovaries. Estrogen-based replacement therapy is the main stay of treatment for women with POF and is recommended at least until the average age of natural menopause (52 years in the UK). This view is endorsed by regulatory bodies such as the Committee on Safety of Medicines (now the Commission on Human Medicines) in the UK. No evidence shows that estrogen replacement increases the risk of breast cancer to a level greater than that found in normally menstruating women, and women with POF do not need to start mammographic screening early unless other risk factors are present, such as family history.

Для цитирования: Pitkin Joan, Rees Margaret C P, Gray Sarah, Lumsden Mary Ann, Marsden Jo, Stevenson John C, Williamson Jennifer. Management of premature menopause.. Menopause international. 2007. DOI: 10.1258/175404507780456719.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.